Difference between revisions of "Urothelial carcinoma"

Jump to navigation Jump to search
Line 152: Line 152:


=Molecular=
=Molecular=
*Usually ''not'' used for diagnosis.
*Molecular testing usually ''not'' used for diagnosis.
**Molecular subtyping can be approximated with immunostaining - see ''[[Classification of urothelial carcinoma by immunohistochemistry]]''.


Changes:
Changes:
*9p deletion -- site of CDKN2A<ref name=omim600160>{{OMIM|600160}}</ref> (AKA p16).
*9p deletion -- site of CDKN2A<ref name=omim600160>{{OMIM|600160}}</ref> (AKA p16).
*17p deletion -- site of PT53 (AKA p53).
*17p deletion -- site of PT53 (AKA p53).
Molecular subtyping can be approximated with immunostaining - see ''[[Classification of urothelial carcinoma by immunohistochemistry]]''.


=Sign out=
=Sign out=
48,460

edits

Navigation menu